It’s Time to Evolve Beyond FMTs and Advance LBPs
The FMT era has been productive, but now it’s time to rally together as an industry to accelerate next-generation LBP drug discovery, development and FDA approval.
The FMT era has been productive, but now it’s time to rally together as an industry to accelerate next-generation LBP drug discovery, development and FDA approval.
A 32-year-old woman infected with Clostridium difficile was recently successfully treated with a fecal transplant, an emerging option for people who suffer from different gastrointestinal diseases, commonly caused by antibiotics. The idea is to take donor fecal matter (that has been rinsed and strained) and with either an enema, endoscopy or pill form, replace healthy […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Next-gen fecal transplant company Rebiotix seems to be in the midst of a rather hefty funding round. The Minnesota-based startup filed equity-raising paperwork with the Securities and Exchange Commission to the tune of $25 million. According to the filing, Rebiotix has raised $18 million thus far. Rebiotix was founded in 2011, and raised about $5 million then from angel investors. […]